Showing results (1091-1100 of 1,593) with videos related to
Sort By:
Pageof 160
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survivalCristiam M Alvarez, Gerhard Opelz, Mabel C Giraldo, et al.Transplantation Proceedings|June 4, 2013
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effectsF C Renner, H Dietrich, N Bulut, et al.Journal of Hospital Medicine|May 2, 2017
Planning and Designing the Improving Addiction Care Team (IMPACT) for Hospitalized Adults with Substance Use DisorderHonora Englander, Melissa Weimer, Rachel Solotaroff, et al.ACS Applied Materials & Interfaces|June 4, 2015
Solvent Control of Surface Plasmon-Mediated Chemical Deposition of Au Nanoparticles from Alkylgold Phosphine ComplexesChristopher L Muhich, Jingjing Qiu, Aaron M Holder, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2009
Differential requirements for clathrin in receptor-mediated endocytosis and maintenance of synaptic vesicle poolsKen Sato, Glen G Ernstrom, Shigeki Watanabe, et al.Cancers|January 11, 2022
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast CancerInken Flörkemeier, Tamara N Steinhauer, Nina Hedemann, et al.Transplant Immunology|April 28, 2018
Changes of NK cell subsets with time post-transplant in peripheral blood of renal transplant recipientsLi Zhu, Mostafa Aly, Haihao Wang, et al.Human Biology|April 1, 1997
Evolutionary and anthropological implications of mitochondrial DNA variation in African Brazilian populationsM C Bortolini, M A Zago, F M Salzano, et al.Plos One|May 3, 2017
A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapiesRyan D Geraets, Logan M Langin, Jacob T Cain, et al.The Annals of Pharmacotherapy|March 18, 2003
Branded versus generic clozapine for treatment of schizophreniaEugene H Makela, William D Cutlip, James M Stevenson, et al.Pageof 160